Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care

OBJECTIVE: Approximately 5% of patients with coronavirus disease 2019 (COVID-19) develop a life-threatening pneumonia that often occurs in the setting of increased inflammation or “cytokine storm”. Anti-cytokine treatments are being evaluated but optimal patient selection remains unclear, and the ai...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Virol
Asıl Yazarlar: Quartuccio, Luca, Sonaglia, Arianna, McGonagle, Dennis, Fabris, Martina, Peghin, Maddalena, Pecori, Davide, De Monte, Amato, Bove, Tiziana, Curcio, Francesco, Bassi, Flavio, De Vita, Salvatore, Tascini, Carlo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier B.V. 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227535/
https://ncbi.nlm.nih.gov/pubmed/32570043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcv.2020.104444
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller